# Respiratory outcomes of adrenergic beta-antagonists in patients undergoing tracheal extubation: a systematic review and meta-analysis of randomized controlled trials

**Authors:** Lucas Cael Azevedo Ramos Bendaham, Altair Pereira de Melo Neto, Hilária Saugo Faria, André Richard da Silva Oliveira Filho, Carlos Henrique de Oliveira Ferreira, Marcela da Silva Kazitani Cunha, Victor Gonçalves Soares, Ocílio Ribeiro Gonçalves, Milene Vitória Sampaio Sobral, Mohamed Doma, Denis Maltz Grutcki, Fabrício Tavares Mendonça

PMC · DOI: 10.1016/j.bjane.2025.844659 · Brazilian Journal of Anesthesiology · 2025-07-05

## TL;DR

This study finds that beta-blockers reduce cough and hypertension during tracheal extubation after anesthesia, with no significant increase in bronchospasm or bucking.

## Contribution

A systematic review and meta-analysis showing beta-blockers' effectiveness in reducing peri-extubation complications.

## Key findings

- Beta-blockers significantly reduced moderate/severe cough compared to placebo.
- Hypertension risk was also significantly lower in the beta-blocker group.
- No significant differences were found in bronchospasm or bucking between groups.

## Abstract

Tracheal extubation after general anesthesia may cause hemodynamic and respiratory complications, with no established strategies to prevent them. We conducted a meta-analysis to evaluate the safety and efficacy of beta-blockers in patients undergoing tracheal extubation.

We searched the MEDLINE, EMBASE and CENTRAL databases for randomized controlled trials up to 2024 comparing beta-blockers to placebo in patients undergoing tracheal extubation. Primary outcome: cough intensity; secondary: bronchospasm, bucking, hypertension. Risk Ratios (RR) with 95% Confidence Intervals (95% CI) were computed. Leave-one-out sensitivity and meta-regression analyses were performed for outcomes with high heterogeneity.

We included 31 randomized studies, comprising 1,803 patients, of whom 965 received beta-blockers. The risk of moderate/severe cough (RR = 0.21; 95% CI 0.13 to 0.34; p < 0.001; I2 = 0%) and hypertension (RR = 0.28; 95% CI 0.13 to 0.58; p < 0.001; I2 = 45%) was significantly lower in the beta-blockers group compared with the placebo group. There were no statistically significant differences between groups in the risk of bronchospasm (RR = 0.58; 95% CI 0.17 to 1.94; p = 0.375; I2 = 0%) or bucking (RR = 0.47; 95% CI 0.20 to 1.13; p = 0.093; I2 = 72%). Sensitivity analysis identified Mendonça (2023) as the main heterogeneity source in bucking.

Our study demonstrates that beta-blockers reduced moderate/severe cough and hypertension in patients undergoing tracheal extubation compared with placebo with no significant difference in the risk of bronchospasm and bucking. These findings suggest beta-blockers may be a valuable strategy for preventing peri-extubation hemodynamic instability and airway hyperresponsiveness.

CRD42024542103.

## Full-text entities

- **Diseases:** cough (MESH:D003371), bronchospasm (MESH:D001986), respiratory complications (MESH:D012140), hypertension (MESH:D006973)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12345278/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12345278/full.md

## References

62 references — full list in the complete paper: https://tomesphere.com/paper/PMC12345278/full.md

---
Source: https://tomesphere.com/paper/PMC12345278